Common Drug Review (CDR) Submission Deadlines and CDEC Meeting Dates

In the past, as CADTH does not have submission deadlines and submissions are reviewed on an ongoing basis, manufacturers could determine the tentative date when their submission would be considered based on the date the drug submission was received, the date it was deemed complete and other factors. However due to the recent queuing of submissions, CADTH has altered the way that targeted meeting dates are assigned.

Targeted meeting dates are now determined considering the date that the submission or resubmission is accepted for review by CADTH. CADTH still accepts applications for submissions and resubmissions for review through the CDR process at any time, therefore manufacturers are encouraged to file as soon as possible. All submissions and resubmissions will be assigned to the CDR work schedule for initiation of the review on a first-come, first-served basis as determined by the date the submission or resubmission is accepted for review by CADTH. Exceptions include submissions and resubmissions granted priority review status, requests for advice, and drug plan-initiated submissions or resubmissions.

Review Initiated By: Targeted CDEC Meeting Date:
2016-Dec-09 2017-Apr-19
2017-Jan-16 2017-May-17
2017-Feb-17 2017-Jun-21
2017-Mar-17 2017-Jul-19
2017-May-18 2017-Sep-20
2017-Jun-15 2017-Oct-18
2017-Jul-14 2017-Nov-15
Sep 11, 2017 Jan 17, 2018
Oct 16, 2017 Feb 21, 2018
Nov 13, 2017 Mar 21, 2018
Dec 08, 2017 Apr 18, 2018
Jan 15, 2018 May 16, 2018
Feb 16, 2018 Jun 20, 2018
Mar 16, 2018 Jul 18, 2018
May 17, 2018 Sep 19, 2018
Jun 14, 2018 Oct 17, 2018
Jul 20, 2018 Nov 21, 2018

*CADTH may add an August and/or December CDEC meeting when workload necessitates.